# Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis

> **NCT01905423** · — · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 17108 (actual)

## Conditions studied

- Lymphatic Filariasis
- Soil Transmitted Helminth Infections

## Interventions

- **DRUG:** Albendazole (annual)
- **DRUG:** Diethylcarbamazine (annual)
- **DRUG:** Albendazole (semiannual)
- **DRUG:** Diethylcarbamazine (semiannual)

## Key facts

- **NCT ID:** NCT01905423
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2015-03
- **Final completion:** 2015-12
- **Target enrollment:** 17108 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01905423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01905423, "Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01905423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*